THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
发明人:
WYKES, MICHELLE
申请号：
CA3033105
公开号：
CA3033105A1
申请日:
2016.08.11
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
Disclosed are compounds for use in modulating immune responses. More particularly, the present invention discloses oligomeric forms of PD-L2 for use in modulating Th1 immune responses. The compounds of the present invention find utility in a range of Th1-mediated disorders including pathogenic infections and hyperproliferative disorders.
